Reported Sep 2, 2026 · Ongoing · Updated Sep 16, 2026
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05)…
Hikma Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hikma Pharmaceuticals USA INC. · 1809 Wilson Rd · Columbus, OH · 43228-9579
Is this the product you have?
- Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only
- Manufactured forExelan Pharmaceuticals, Inc., Boca Raton, FL 33432
- Manufactured byWest-Ward Columbus Inc., Columbus, OH 43228
- Lot codes and dates
a) Lot #: AC5470AExp. Date July 2027 b) Lot #: AC5470BExp. Date July 2027
- Amount recalled
- a) 25,970 bottles; b) 2,384 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hikma Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.